fda glp-1 shortage list lawsuit As of February 21, 2025, the updated its drug list, marking the semaglutide injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Compounders Sue FDA for Declaring

Description

The potential interaction between TRPV1 and GLP-1-derived peptides has been elucidated through structural models

Notably, GLP-1 receptor agonists also slow biliary motility, which can contribute to the development of bile ductblocking sludge and stones, resulting in acute pancreatitis

Reality checks, deposit caps, time limits, and self-exclusion tools are most effective when they are easy to set and hard to ignore

The launch of oral GLP-1s coupled with lower prices and broader access (including Medicare and Medicaid coverage in the U.S.) should drive higher utilization and market penetration as more affordable and convenient options become available, Schott said